Myllia Biotechnology
@mylliabio.bsky.social
Primary cell CRISPR screens to accelerate drug discovery and target selection at single-cell resolution
Time to announce another speaker for #Perturb2027
Meet the speaker: @anshulkundaje.bsky.social
Associate Professor at Stanford University, get to know Dr. Kundaje and learn about his research with machine learning models of gene regulation:
shorturl.at/h1I6r
Meet the speaker: @anshulkundaje.bsky.social
Associate Professor at Stanford University, get to know Dr. Kundaje and learn about his research with machine learning models of gene regulation:
shorturl.at/h1I6r
October 8, 2026 at 1:05 PM
Time to announce another speaker for #Perturb2027
Meet the speaker: @anshulkundaje.bsky.social
Associate Professor at Stanford University, get to know Dr. Kundaje and learn about his research with machine learning models of gene regulation:
shorturl.at/h1I6r
Meet the speaker: @anshulkundaje.bsky.social
Associate Professor at Stanford University, get to know Dr. Kundaje and learn about his research with machine learning models of gene regulation:
shorturl.at/h1I6r
Next week, Myllia is headed to London for @elrig.org Drug Discovery 2026
Join our flash talk presentation on Day 1 (Oct. 14) at 2:30 PM in the session “CRISPR/Cas technologies from discovery to therapeutic application” and visit our booth (F06) and poster (#300)
🔗 myllia.com/events/drug-...
Join our flash talk presentation on Day 1 (Oct. 14) at 2:30 PM in the session “CRISPR/Cas technologies from discovery to therapeutic application” and visit our booth (F06) and poster (#300)
🔗 myllia.com/events/drug-...
October 6, 2026 at 9:26 AM
Next week, Myllia is headed to London for @elrig.org Drug Discovery 2026
Join our flash talk presentation on Day 1 (Oct. 14) at 2:30 PM in the session “CRISPR/Cas technologies from discovery to therapeutic application” and visit our booth (F06) and poster (#300)
🔗 myllia.com/events/drug-...
Join our flash talk presentation on Day 1 (Oct. 14) at 2:30 PM in the session “CRISPR/Cas technologies from discovery to therapeutic application” and visit our booth (F06) and poster (#300)
🔗 myllia.com/events/drug-...
Myllia is on the move this autumn season!
We’re looking forward to connecting with the biotech and pharma community across Europe and the US at major Q4 events – including ELRIG's Drug Discovery, AI Drug Discovery and Development, BIO Europe, and more...
Learn more: myllia.com/biotechnolog...
We’re looking forward to connecting with the biotech and pharma community across Europe and the US at major Q4 events – including ELRIG's Drug Discovery, AI Drug Discovery and Development, BIO Europe, and more...
Learn more: myllia.com/biotechnolog...
October 2, 2026 at 2:21 PM
Myllia is on the move this autumn season!
We’re looking forward to connecting with the biotech and pharma community across Europe and the US at major Q4 events – including ELRIG's Drug Discovery, AI Drug Discovery and Development, BIO Europe, and more...
Learn more: myllia.com/biotechnolog...
We’re looking forward to connecting with the biotech and pharma community across Europe and the US at major Q4 events – including ELRIG's Drug Discovery, AI Drug Discovery and Development, BIO Europe, and more...
Learn more: myllia.com/biotechnolog...
Join Myllia on October 8th at the Single Cell & Spatial CRO Summit organized by @10xgenomics.bsky.social
Taking the stage at 13:30 CET, tune in for a talk held by Neil Matharoo, our VP, Commercial – North America
📅 Date: October 8, 2026
🕐 Time: 1–3 PM CEST
🔗 myllia.com/events/10x-s...
Taking the stage at 13:30 CET, tune in for a talk held by Neil Matharoo, our VP, Commercial – North America
📅 Date: October 8, 2026
🕐 Time: 1–3 PM CEST
🔗 myllia.com/events/10x-s...
September 30, 2026 at 10:13 AM
Join Myllia on October 8th at the Single Cell & Spatial CRO Summit organized by @10xgenomics.bsky.social
Taking the stage at 13:30 CET, tune in for a talk held by Neil Matharoo, our VP, Commercial – North America
📅 Date: October 8, 2026
🕐 Time: 1–3 PM CEST
🔗 myllia.com/events/10x-s...
Taking the stage at 13:30 CET, tune in for a talk held by Neil Matharoo, our VP, Commercial – North America
📅 Date: October 8, 2026
🕐 Time: 1–3 PM CEST
🔗 myllia.com/events/10x-s...
Meet the speaker #2: Junyue Cao
Earning his PhD from the University of Washington, Dr. Junyue Cao went on to lead the Laboratory of Single-Cell Genomics and Population Dynamics at The Rockefeller University. Learn more about him: myllia.com/news/meet-th...
Info on Perturb'27: www.perturb2027.bio
Earning his PhD from the University of Washington, Dr. Junyue Cao went on to lead the Laboratory of Single-Cell Genomics and Population Dynamics at The Rockefeller University. Learn more about him: myllia.com/news/meet-th...
Info on Perturb'27: www.perturb2027.bio
September 28, 2026 at 1:11 PM
Meet the speaker #2: Junyue Cao
Earning his PhD from the University of Washington, Dr. Junyue Cao went on to lead the Laboratory of Single-Cell Genomics and Population Dynamics at The Rockefeller University. Learn more about him: myllia.com/news/meet-th...
Info on Perturb'27: www.perturb2027.bio
Earning his PhD from the University of Washington, Dr. Junyue Cao went on to lead the Laboratory of Single-Cell Genomics and Population Dynamics at The Rockefeller University. Learn more about him: myllia.com/news/meet-th...
Info on Perturb'27: www.perturb2027.bio
With registrations open, it is time to start announcing the line up of speakers that will take the stage at Perturb 2027!
Meet the speaker: Brian Brown myllia.com/news/meet-br...
Early bird tickets for Perturb 2027 are now available on the conference website: www.perturb2027.bio
Meet the speaker: Brian Brown myllia.com/news/meet-br...
Early bird tickets for Perturb 2027 are now available on the conference website: www.perturb2027.bio
September 24, 2026 at 11:30 AM
With registrations open, it is time to start announcing the line up of speakers that will take the stage at Perturb 2027!
Meet the speaker: Brian Brown myllia.com/news/meet-br...
Early bird tickets for Perturb 2027 are now available on the conference website: www.perturb2027.bio
Meet the speaker: Brian Brown myllia.com/news/meet-br...
Early bird tickets for Perturb 2027 are now available on the conference website: www.perturb2027.bio
Registration for Perturb 2027: High-Content CRISPR Screening Conference in NYC is now open!
Acquire your ticket at an unbeatable price – and don’t wait too long! Early bird tier tickets are limited until December 15th or to the existing stock (120 tickets). Visit www.perturb2027.bio to learn more.
Acquire your ticket at an unbeatable price – and don’t wait too long! Early bird tier tickets are limited until December 15th or to the existing stock (120 tickets). Visit www.perturb2027.bio to learn more.
September 16, 2026 at 3:56 PM
Registration for Perturb 2027: High-Content CRISPR Screening Conference in NYC is now open!
Acquire your ticket at an unbeatable price – and don’t wait too long! Early bird tier tickets are limited until December 15th or to the existing stock (120 tickets). Visit www.perturb2027.bio to learn more.
Acquire your ticket at an unbeatable price – and don’t wait too long! Early bird tier tickets are limited until December 15th or to the existing stock (120 tickets). Visit www.perturb2027.bio to learn more.
What primary human cell models can we work with at Myllia?
Explore our new interactive human body illustration to discover how we apply high-content CRISPR screening across a broad range of therapeutic areas.
Have a look here: myllia.com
Explore our new interactive human body illustration to discover how we apply high-content CRISPR screening across a broad range of therapeutic areas.
Have a look here: myllia.com
September 10, 2026 at 11:37 AM
What primary human cell models can we work with at Myllia?
Explore our new interactive human body illustration to discover how we apply high-content CRISPR screening across a broad range of therapeutic areas.
Have a look here: myllia.com
Explore our new interactive human body illustration to discover how we apply high-content CRISPR screening across a broad range of therapeutic areas.
Have a look here: myllia.com
Myllia is a co-author on "Predicting cellular responses to perturbation across diverse contexts with State" — just published in @cellpress.bsky.social! State is a foundation model predicting how cells respond to genetic & chemical perturbations across diverse contexts (1/2)
cell.com/cell/fulltex...
cell.com/cell/fulltex...
September 1, 2026 at 2:45 PM
Myllia is a co-author on "Predicting cellular responses to perturbation across diverse contexts with State" — just published in @cellpress.bsky.social! State is a foundation model predicting how cells respond to genetic & chemical perturbations across diverse contexts (1/2)
cell.com/cell/fulltex...
cell.com/cell/fulltex...
Teamwork makes the dreamwork! Every individual at Myllia plays an important role in advancing science and helping CROP-Seq data reach companies working on target discovery. Today, we’re proud to highlight the employees that are part of #TeamMyllia
🔗 myllia.com/about-us/
🔗 myllia.com/about-us/
July 22, 2026 at 2:59 PM
Teamwork makes the dreamwork! Every individual at Myllia plays an important role in advancing science and helping CROP-Seq data reach companies working on target discovery. Today, we’re proud to highlight the employees that are part of #TeamMyllia
🔗 myllia.com/about-us/
🔗 myllia.com/about-us/
Following the success of “Perturb 2026: High-Content CRISPR Screening”, we’re proud to announce the second edition of the conference to take place from 17th to 18th of March 2027. This time, we’re heading Stateside to one of the busiest cities on the planet: New York City!
🔗 www.perturb2027.bio
🔗 www.perturb2027.bio
July 16, 2026 at 2:34 PM
Following the success of “Perturb 2026: High-Content CRISPR Screening”, we’re proud to announce the second edition of the conference to take place from 17th to 18th of March 2027. This time, we’re heading Stateside to one of the busiest cities on the planet: New York City!
🔗 www.perturb2027.bio
🔗 www.perturb2027.bio
People of #TeamMyllia
Our most recent group picture features almost everyone in the team, reflecting how international, multifaceted and diverse our company has become.
Learn more about us: myllia.com/about-us/
Our most recent group picture features almost everyone in the team, reflecting how international, multifaceted and diverse our company has become.
Learn more about us: myllia.com/about-us/
July 9, 2026 at 12:08 PM
People of #TeamMyllia
Our most recent group picture features almost everyone in the team, reflecting how international, multifaceted and diverse our company has become.
Learn more about us: myllia.com/about-us/
Our most recent group picture features almost everyone in the team, reflecting how international, multifaceted and diverse our company has become.
Learn more about us: myllia.com/about-us/
Optical pooled screens combine genetic perturbations with microscopy-based phenotypic readouts. In this data spotlight, Myllia’s CRISPR screening technology was combined with Element Biosciences’ AVITI24™ instrument to identify regulators of NF-κB signalling in a HeLa cell line. (1/5)
July 2, 2026 at 2:57 PM
Optical pooled screens combine genetic perturbations with microscopy-based phenotypic readouts. In this data spotlight, Myllia’s CRISPR screening technology was combined with Element Biosciences’ AVITI24™ instrument to identify regulators of NF-κB signalling in a HeLa cell line. (1/5)
We’re live at the Single-Cell & Spatial Day in Basel! Sumit has just presented our VISTA technology platform, highlighting how we can perform single-cell CRISPR screening in primary human macrophages and dendritic cells to enable unbiased drug target discovery.
June 18, 2026 at 10:16 AM
We’re live at the Single-Cell & Spatial Day in Basel! Sumit has just presented our VISTA technology platform, highlighting how we can perform single-cell CRISPR screening in primary human macrophages and dendritic cells to enable unbiased drug target discovery.
Myllia is heading to the 4th Basel Single Cell & Spatial Day! 🚀
Meet Anke and Sumit at our booth to discuss CRISPR screens for drug target discovery. Don’t miss Sumit’s 10:10 talk on single-cell CRISPR screens in primary human cells.
More info: myllia.com/events/4th-s...
Meet Anke and Sumit at our booth to discuss CRISPR screens for drug target discovery. Don’t miss Sumit’s 10:10 talk on single-cell CRISPR screens in primary human cells.
More info: myllia.com/events/4th-s...
June 16, 2026 at 9:52 AM
Myllia is heading to the 4th Basel Single Cell & Spatial Day! 🚀
Meet Anke and Sumit at our booth to discuss CRISPR screens for drug target discovery. Don’t miss Sumit’s 10:10 talk on single-cell CRISPR screens in primary human cells.
More info: myllia.com/events/4th-s...
Meet Anke and Sumit at our booth to discuss CRISPR screens for drug target discovery. Don’t miss Sumit’s 10:10 talk on single-cell CRISPR screens in primary human cells.
More info: myllia.com/events/4th-s...
Stefanie is heading to Berlin to represent Myllia at Discovery & Development Europe 2026
She will present a poster on how pooled CRISPR screenings were combined with InTraSeq, a single-cell method that measures RNA alongside intracellular and surface proteins.
🔗 shorturl.at/2XihX @cellsignal.com
She will present a poster on how pooled CRISPR screenings were combined with InTraSeq, a single-cell method that measures RNA alongside intracellular and surface proteins.
🔗 shorturl.at/2XihX @cellsignal.com
June 11, 2026 at 12:26 PM
Stefanie is heading to Berlin to represent Myllia at Discovery & Development Europe 2026
She will present a poster on how pooled CRISPR screenings were combined with InTraSeq, a single-cell method that measures RNA alongside intracellular and surface proteins.
🔗 shorturl.at/2XihX @cellsignal.com
She will present a poster on how pooled CRISPR screenings were combined with InTraSeq, a single-cell method that measures RNA alongside intracellular and surface proteins.
🔗 shorturl.at/2XihX @cellsignal.com
Join us on June 16th at 2PM CET for a hybrid seminar with Element Biosciences! Molly He, Matthew Gow, and Tillmann Burckstümmer will discuss single-cell multiomics, NGS, and how optical pooled CRISPR screening identified NF-κB regulators in human cells
Learn more and register: shorturl.at/6VQkD
Learn more and register: shorturl.at/6VQkD
June 5, 2026 at 10:03 AM
Join us on June 16th at 2PM CET for a hybrid seminar with Element Biosciences! Molly He, Matthew Gow, and Tillmann Burckstümmer will discuss single-cell multiomics, NGS, and how optical pooled CRISPR screening identified NF-κB regulators in human cells
Learn more and register: shorturl.at/6VQkD
Learn more and register: shorturl.at/6VQkD
We’re heading to #BIO2026!
Connect with Myllia as we share how our high-content CRISPR screening technology can fuel drug target discovery. Stay tuned for more details on where to find us and what we’ll be showcasing.
Book a meeting with us: convention.bio.org/partner
Connect with Myllia as we share how our high-content CRISPR screening technology can fuel drug target discovery. Stay tuned for more details on where to find us and what we’ll be showcasing.
Book a meeting with us: convention.bio.org/partner
June 3, 2026 at 7:56 AM
We’re heading to #BIO2026!
Connect with Myllia as we share how our high-content CRISPR screening technology can fuel drug target discovery. Stay tuned for more details on where to find us and what we’ll be showcasing.
Book a meeting with us: convention.bio.org/partner
Connect with Myllia as we share how our high-content CRISPR screening technology can fuel drug target discovery. Stay tuned for more details on where to find us and what we’ll be showcasing.
Book a meeting with us: convention.bio.org/partner
Two weeks to our Element Biosciences webinar! Tillmann Burckstummer and Jens Durruthy Durruthy will take the stage to discuss how optical pooled CRISPR screens revealed NF-kB regulators in human cells.
📅 June 10th
🕑09:00 PDT/ 12:00 EDT/ 16:00 GMT
🔗https://shorturl.at/3DGEf
📅 June 10th
🕑09:00 PDT/ 12:00 EDT/ 16:00 GMT
🔗https://shorturl.at/3DGEf
May 29, 2026 at 10:07 AM
Two weeks to our Element Biosciences webinar! Tillmann Burckstummer and Jens Durruthy Durruthy will take the stage to discuss how optical pooled CRISPR screens revealed NF-kB regulators in human cells.
📅 June 10th
🕑09:00 PDT/ 12:00 EDT/ 16:00 GMT
🔗https://shorturl.at/3DGEf
📅 June 10th
🕑09:00 PDT/ 12:00 EDT/ 16:00 GMT
🔗https://shorturl.at/3DGEf
Myllia is attending SLAS Europe in Vienna!
May 19th - Henrik, our VP Commercial, will present Myllia's high-content CRISPR screening platform.
May 20th - Tilmann, CSO, will showcase how our VISTA platform deciphers primary human macrophage biology.
🔗https://shorturl.at/PEbuc
May 19th - Henrik, our VP Commercial, will present Myllia's high-content CRISPR screening platform.
May 20th - Tilmann, CSO, will showcase how our VISTA platform deciphers primary human macrophage biology.
🔗https://shorturl.at/PEbuc
May 15, 2026 at 8:14 AM
Myllia is attending SLAS Europe in Vienna!
May 19th - Henrik, our VP Commercial, will present Myllia's high-content CRISPR screening platform.
May 20th - Tilmann, CSO, will showcase how our VISTA platform deciphers primary human macrophage biology.
🔗https://shorturl.at/PEbuc
May 19th - Henrik, our VP Commercial, will present Myllia's high-content CRISPR screening platform.
May 20th - Tilmann, CSO, will showcase how our VISTA platform deciphers primary human macrophage biology.
🔗https://shorturl.at/PEbuc
Meet Myllia Biotechnology at #CIMT2026 in Mainz 🇩🇪
Our Assoc. Director of R&D, Sumit, will present on pooled CRISPR screening for drug target discovery in primary human macrophages—highlighting our VISTA platform.
📅 May 11–13
👉 myllia.com/events/cimt-...
Our Assoc. Director of R&D, Sumit, will present on pooled CRISPR screening for drug target discovery in primary human macrophages—highlighting our VISTA platform.
📅 May 11–13
👉 myllia.com/events/cimt-...
May 8, 2026 at 2:01 PM
Meet Myllia Biotechnology at #CIMT2026 in Mainz 🇩🇪
Our Assoc. Director of R&D, Sumit, will present on pooled CRISPR screening for drug target discovery in primary human macrophages—highlighting our VISTA platform.
📅 May 11–13
👉 myllia.com/events/cimt-...
Our Assoc. Director of R&D, Sumit, will present on pooled CRISPR screening for drug target discovery in primary human macrophages—highlighting our VISTA platform.
📅 May 11–13
👉 myllia.com/events/cimt-...
🚀 Are you ready to push the boundaries of bio AI foundation models? @mylliabio.bsky.social is thrilled to host "Echoes of Silenced Genes" - A Global Community Prediction Competition!
🔗 Learn more here and join the competition:
myllia.com/events/commu...
#AI #BioAI #CRISPR #Perturb2026
🔗 Learn more here and join the competition:
myllia.com/events/commu...
#AI #BioAI #CRISPR #Perturb2026
February 4, 2026 at 10:58 AM
🚀 Are you ready to push the boundaries of bio AI foundation models? @mylliabio.bsky.social is thrilled to host "Echoes of Silenced Genes" - A Global Community Prediction Competition!
🔗 Learn more here and join the competition:
myllia.com/events/commu...
#AI #BioAI #CRISPR #Perturb2026
🔗 Learn more here and join the competition:
myllia.com/events/commu...
#AI #BioAI #CRISPR #Perturb2026
Reposted by Myllia Biotechnology
Kick off 2026 with a deep dive into single-cell science! 🚀
Join FGCZ & BD Biosciences on March 9 in Zurich for the BD Rhapsody™ Science Days.
Featuring:
🔬 Dr. Simone Picelli (IOB, Basel)
🧬 @mylliabio.bsky.social
🩺 Dr. Marc Beyer (DZNE, Bonn)
✨ Dr. Luciano Martelotto (BD)
🔗 tinyurl.com/wbffw5an
Join FGCZ & BD Biosciences on March 9 in Zurich for the BD Rhapsody™ Science Days.
Featuring:
🔬 Dr. Simone Picelli (IOB, Basel)
🧬 @mylliabio.bsky.social
🩺 Dr. Marc Beyer (DZNE, Bonn)
✨ Dr. Luciano Martelotto (BD)
🔗 tinyurl.com/wbffw5an
February 2, 2026 at 12:18 PM
Kick off 2026 with a deep dive into single-cell science! 🚀
Join FGCZ & BD Biosciences on March 9 in Zurich for the BD Rhapsody™ Science Days.
Featuring:
🔬 Dr. Simone Picelli (IOB, Basel)
🧬 @mylliabio.bsky.social
🩺 Dr. Marc Beyer (DZNE, Bonn)
✨ Dr. Luciano Martelotto (BD)
🔗 tinyurl.com/wbffw5an
Join FGCZ & BD Biosciences on March 9 in Zurich for the BD Rhapsody™ Science Days.
Featuring:
🔬 Dr. Simone Picelli (IOB, Basel)
🧬 @mylliabio.bsky.social
🩺 Dr. Marc Beyer (DZNE, Bonn)
✨ Dr. Luciano Martelotto (BD)
🔗 tinyurl.com/wbffw5an
We’re thrilled to announce that the "High-Content CRISPR Screening" conference will take place from March 18–19, 2026, in Vienna, Austria. The early-bird registration is open via the conference website:
www.perturb2026.bio
Meet the Speaker: Sami Farhi
www.perturb2026.bio
Meet the Speaker: Sami Farhi
December 9, 2025 at 1:11 PM
We’re thrilled to announce that the "High-Content CRISPR Screening" conference will take place from March 18–19, 2026, in Vienna, Austria. The early-bird registration is open via the conference website:
www.perturb2026.bio
Meet the Speaker: Sami Farhi
www.perturb2026.bio
Meet the Speaker: Sami Farhi
Are you interested in single-cell genomics, AI-ready perturbation data and virtual cell models? The registration for the "High-Content CRISPR Screening" conference in March 2026 is open via the website:
perturb2026.bio
Meet the Speaker: Ci Chu
perturb2026.bio
Meet the Speaker: Ci Chu
December 2, 2025 at 9:13 AM
Are you interested in single-cell genomics, AI-ready perturbation data and virtual cell models? The registration for the "High-Content CRISPR Screening" conference in March 2026 is open via the website:
perturb2026.bio
Meet the Speaker: Ci Chu
perturb2026.bio
Meet the Speaker: Ci Chu